A $2.5 million jury verdict against Johnson & Johnson’s Janssen Pharmaceuticals involving claims the company’s antipsychotic drug Risperdal caused an autistic boy to grow female breasts will stand, a Philadelphia judge ruled. Philadelphia County Court of Common Pleas Judge Ramy I. Djerassi rejected the drug company’s bid for a new trial based on claims that allowing a new expert in the bellwether trial had left Janssen’s attorneys unprepared for the new testimony. The drug company also argued that the $2.5 million verdict was excessive because it relied on the plaintiff’s mother’s accounts of her son’s experiences after growing breasts. Djerassi ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.